Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/6/2025

Prednisone Tapering Guidelines

Introduction to Tapering

  • A standard 2-week prednisone taper starts with 40mg daily for 3-4 days, then reduces by 5mg every 2-3 days until completion, as recommended by clinical guidelines 1
  • For short courses (2 weeks), a structured taper helps prevent rebound symptoms and minimize risk of adrenal insufficiency 1

Tapering Schedules

  • The American College of Physicians recommends a tapering schedule for prednisone, starting with 40mg daily for days 1-3, 35mg daily for days 4-5, 30mg daily for days 6-7, 25mg daily for days 8-9, 20mg daily for days 10-11, 15mg daily for days 12-13, and 10mg daily on day 14, then 5mg daily on day 15, according to the Mayo Clinic Proceedings 1
  • A more gradual taper for higher risk of rebound can be used, with 40mg daily for days 1-3, 30mg daily for days 4-6, 20mg daily for days 7-9, 10mg daily for days 10-12, and 5mg daily for days 13-14, as suggested by the Mayo Clinic Proceedings 2

Special Populations

  • For inflammatory conditions requiring higher initial doses (>30mg), the Mayo Clinic recommends starting at 60mg daily for 2-3 days, then following the taper schedule above 2
  • For polymyalgia rheumatica, the European League Against Rheumatism recommends tapering to 10mg/day within 4-8 weeks, then reducing by 1mg every 4 weeks until discontinuation 3
  • For moderate immune-related adverse events, the Society for Immunotherapy of Cancer recommends starting at 0.5-1mg/kg/day and tapering over 2 weeks once symptoms improve 4
  • For severe immune-related adverse events, the Society for Immunotherapy of Cancer recommends starting at 1-2mg/kg/day and tapering over 4-6 weeks 4

Managing Potential Complications

  • If symptoms recur during tapering, the American College of Rheumatology recommends returning to the pre-relapse dose and decreasing more gradually (within 4-8 weeks) to the dose at which the relapse occurred 3
  • The Endocrine Society recommends monitoring for signs of adrenal insufficiency during tapering (fatigue, weakness, dizziness, nausea) 1
  • For patients with diabetes, the American Diabetes Association recommends more frequent blood glucose monitoring during the taper 1

Common Pitfalls to Avoid

  • Tapering too quickly can lead to disease flare or adrenal insufficiency, as warned by the American College of Physicians 1
  • Not providing patients with clear instructions about the tapering schedule can lead to non-adherence, according to clinical guidelines 1

Evidence on Tapering vs. Fixed Dosing

  • For most inflammatory conditions and longer courses of therapy, a structured taper is still recommended to minimize risk of symptom recurrence and adrenal suppression, as suggested by the Mayo Clinic Proceedings and clinical guidelines 2, 1